3-(ethoxycarbonyl)-1-(4-ethylphenyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

5-METHOXYPYRIMIDINE-2,4-DIONE, 97.0%, 1g

2-fluoro-4'-nitrobenzophenone, 97.0%, 1g

2-Bromo-4-chloro-5-iodoanisole, 5g

Methyl 4-(chloromethyl)benzoate, 95.0%, 25g

4,4,5-TRIFLUOROAZEPANE HCL, 95.0%, 1g

5-Amino-2-fluorobenzenesulfonic acid, 95+%, 250mg

(2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate, 97%, 100mg

4-(4,4,5,5-Tetramethyl-1,3,2- dioxaborolan-2-yl)-1H-pyrazole, 98.0%, 500g

Ethyl 2-(2,5-dichloro-phenylamino)-4-methyl-thiazole-5-carboxylate, 99.0%, 1g

1,3-Dibromo-5-(tert-butyl)-2-methoxybenzene, 97%, 5g

Colonna capillare per GC ROTI®Cap-35 MS, 60 m, 0.32 mm, 1 Pezzo(i)

ETHANOL,2-[BIS(2-CHLOROETHYL)AMINO]-,HCL, 95.0%, 250mg